Shots:

• Cipla to acquire 21.85% stake in GoApptiv on a fully diluted basis for ~1.2M (₹9 crores) which included ₹5.80 crores in the first stage and ₹3.20 crores in the second stage. The acquisition will expand the reach of Cipla’s brand in tier three-plus towns
• In the first stage- a subscription of 15-392 compulsorily convertible preference shares and purchase of 6-927 equity shares are expected to be closed within 30 days from the execution date while in the second stage- a subscription of 12-314 compulsorily convertible preference shares is expected to close by Oct 31- 2020
• GoApptiv offers digital solutions for integrated brand sales management- digital marketing- and channel engagement for pharmaceutical companies and provides digital solutions for customer relationship management- patient support- and healthcare data analytics

Click here to read full press release/ article | Ref: Cipla | Image: ET Healthworld